The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.
 
Amylou C. Dueck
Consulting or Advisory Role - Bayer; Phytogine
 
Claus C. Becker
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera
Travel, Accommodations, Expenses - Deciphera
 
Lauren J. Rogak
No Relationships to Disclose
 
Deborah Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - JAMA-Journal of the American Medical Association
Research Funding - AACR (Inst); GRAIL (Inst); Pfizer
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
Travel, Accommodations, Expenses - IMEDEX; Precision Medicine World Conference
Other Relationship - JAMA-Journal of the American Medical Association
 
Bryce Reeve
No Relationships to Disclose
 
Patricia Spears
Consulting or Advisory Role - Pfizer; Pfizer
 
Mary Lou Smith
Consulting or Advisory Role - Novartis
Research Funding - Celgene (Inst); Foundation Medicine (Inst); Genentech (Inst); Genomic Health (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Mrinal M. Gounder
Honoraria - Bayer; Flatiron Health; Medscape; PER
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics; Springworks Therapeutics
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Epizyme
Other Relationship - Desmoid Tumor Research Foundation
(OPTIONAL) Uncompensated Relationships - Foundation Medicine
 
Michelle R. Mahoney
No Relationships to Disclose
 
Gary K. Schwartz
Stock and Other Ownership Interests - Abbott; Abbvie; Becton Dickinson; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Merck; Pfizer
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Bayer; Bionaut Labs; Daiichi Sankyo; Ellipses Pharma; Epizyme; Fortress Biotech; Gencirq; Iovance Biotherapeutics; Pfizer; PTC Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals; Calithera Biosciences (Inst); Daiichi Sankyo (Inst); Fortress Biotech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
Travel, Accommodations, Expenses - Array BioPharma; Array BioPharma; Daiichi Sankyo; Epizyme; Epizyme; Iovance Biotherapeutics; PTC Therapeutics; PureTech
 
Antonia Vickery Bennett
No Relationships to Disclose
 
Tito R. Mendoza
No Relationships to Disclose
 
Charles S. Cleeland
Research Funding - Bayer (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Bayer License agreement to use the MDASI (M D Anderson Symptom Inventory) (Inst)
 
Jeff A. Sloan
No Relationships to Disclose
 
Deborah Bruner
No Relationships to Disclose
 
Gisela Schwab
Employment - Exelixis
 
Thomas Michael Atkinson
No Relationships to Disclose
 
Gita Thanarajasingam
No Relationships to Disclose
 
Monica M. Bertagnolli
Research Funding - Abbvie (Inst); Agenus (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer Health (Inst); Breast Cancer Research Foundation (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chinese Medical Education Association (Inst); Complion (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GHI Pharma (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Leidos (Inst); Leidos (Inst); Lexicon (Inst); Lilly (Inst); Massachusetts General Hospital (Inst); Matrex (Inst); Mayo Clinic (Inst); Merck (Inst); Merck (Inst); Millenium Pharamceuticals (Inst); MITRE Corporation (Inst); Novartis (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Pfizer (Inst); Pharmacyclics (Inst); Robert Wood Johnson Foundation (Inst); Sagerock Advisors (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Teva (Inst)
(OPTIONAL) Uncompensated Relationships - Leap Therapeutics; Syntalogic Pharmaceuticals; Syntimmune
 
Ethan M. Basch
Consulting or Advisory Role - Carevive Systems; Navigating Cancer; SIVAN Innovation
Other Relationship - American Society of Clinical Oncology; Centers for Medicare and Medicaid Services; JAMA-Journal of the American Medical Association; National Cancer Institute; Patient-Centered OUtcomes Research Institute (PCORI)